TrialHematological oncology2025

Treatment-Free Remission in Chronic Phase Chronic Myeloid Leukemia After Nilotinib De-Escalation: 96-Week Update of the DANTE Study.

Alessandra Iurlo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.